Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Ross

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Oncogene|January 17, 2017
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Oncogene|January 17, 2017
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.
Pageof 4